Copyright © 2021. Inderes Oyj. All rights reserved.

CellaVision will host a Capital Markets Day on June 16, 2022. During the day, executive management will present the company’s updated strategic direction, which aims to develop and broaden the company’s operations over the next five years. The event is planned to be held at CellaVision head quarter in Lund. Invitation will be sent out closer to the event.

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China and Japan. The company derives the majority of its revenue from the sale of analyzers.